SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 9,463.00 |
Enterprise Value ($M) | 10,304.71 |
Book Value ($M) | 3,807.76 |
Book Value / Share | 17.20 |
Price / Book | 2.49 |
NCAV ($M) | -159.87 |
NCAV / Share | -0.72 |
Price / NCAV | -59.19 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.06 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | 0.10 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.62 |
Current Ratio | 1.99 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2,147.56 |
Assets | 6,115.19 |
Liabilities | 2,307.43 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1,965.31 |
Operating Income | 453.65 |
Net Income | 341.30 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 459.45 |
Cash from Investing | -87.66 |
Cash from Financing | -433.83 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Massachusetts Financial Services Co /ma/ | 10.50 | -0.26 | |
13G/A | BlackRock Inc. | 12.00 | -12.67 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
97,804 | 954,501 | 10.25 | |
89,574 | 732,909 | 12.22 | |
129,759 | 807,191 | 16.08 | |
81,133 | 913,880 | 8.88 | |
(click for more detail) |
Similar Companies | |
---|---|
PBH – Prestige Consumer Healthcare Inc. | PFE – Pfizer Inc. |
PRGO – Perrigo Company plc | RCUS – Arcus Biosciences, Inc. |
TARO – Taro Pharmaceutical Industries Ltd. |
Financial data and stock pages provided by
Fintel.io